Breast Cancer News
CPRIT awards $13M for prevention, research, recruitment Aug 18, 2017 Researchers in the NCI-designated Dan L Duncan Comprehensive Cancer Center have received $13,107,956 from CPRIT for six new grants.
Annual Metastatic Breast Cancer Conference seeks abstracts May 22, 2017 The Metastatic Breast Cancer Conference is currently seeking abstracts for consideration at the annual conference on Oct. 12 – 13, 2017 at Baylor College of Medicine.
Avon grant supports breast care services for underserved May 8, 2017 Following the annual Avon 39 walk, the Avon Foundation for Women presented Baylor with a grant for $100,000 to support the Lester and Sue Smith Breast Center’s Pink 4 Life project.
New technique tests therapies for breast cancer metastasis Apr 21, 2017 A new laboratory technique can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone.
Novel approach can reveal better breast cancer treatments Mar 28, 2017 Researchers have developed a new way to approach breast cancer treatment by seeking to neutralize specific biological growth drivers.
Scalp cooling effective in reducing hair loss during chemo Feb 14, 2017 Dr. Julie Nangia reports the results of her research studying the effectiveness of scalp cooling therapy in reducing hair loss in women undergoing chemotherapy.
Breast cancer researchers receive $900,000 to support study of treatment resistance, drug efficacy Dec 28, 2016 Dr. Meghashyam Kavuri and Dr. Xi Chen have been awarded grants from the Susan G. Komen Foundation to support their breast cancer research.
Scalp-cooling device cuts hair loss in breast cancer patients undergoing chemotherapy Dec 9, 2016 A scalp cooling cap has been shown to effective in reducing hair loss in breast cancer patients undergoing chemotherapy.
Promising results shown from combination therapy in HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer Dec 8, 2016 A new study reveals the efficacy and safety of treating HER2-positive and hormone receptor-positive metastatic or local advanced breast cancer with pertuzumab in combination with trastuzumab, along with an aromatase inhibitor.
NSABP B52 trial shows estrogen deprivation in neoadjuvant chemotherapy breast cancer treatment is not antagonistic to pathologic complete response Dec 8, 2016 Research by Dr. Mothaffar F. Rimawi he finds that adding an aromatase inhibitor to presurgery breast cancer treatment did not significantly increase or decrease the percentage of patients who experienced a pathologic complete response.